Are you Dr. Tuchman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 34 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
111 Michigan Ave Nw
Washington, DC 20010Phone+1 202-884-2187
Summary
- Dr. Mendel Tuchman, MD is a medical geneticist in Washington, District of Columbia. He is currently licensed to practice medicine in District of Columbia, Maryland, and Virginia. He is a Professor at G Washington University School of Medicine & Hlth Sci.
Education & Training
- University of MinnesotaResidency, Pediatrics, 1980 - 1985
- Tel Aviv University SacklerClass of 1979
- University of MinnesotaFellowship, Medical Genetics and Genomics
Certifications & Licensure
- MD State Medical License 2001 - 2025
- VA State Medical License 2001 - 2022
- DC State Medical License 1999 - 2018
- MN State Medical License 1981 - 2014
- American Board of Pediatrics Pediatrics
Clinical Trials
- Longitudinal Study of Urea Cycle Disorders Start of enrollment: 2006 Feb 01
- N-Carbamylglutamate (Carbaglu) In The Treatment Of Hyperammonemia Start of enrollment: 2008 Aug 01
- PCORI Urea Cycle Disorder Study Start of enrollment: 2016 Mar 04
Publications & Presentations
PubMed
- 25 citationsInversion of allosteric effect of arginine on N-acetylglutamate synthase, a molecular marker for evolution of tetrapodsNantaporn Haskins, Maria Panglao, Qiuhao Qu, Himani Datta Majumdar, Juan Cabrera-Luque
BMC Biochemistry. 2008-09-18 - 129 citationsA longitudinal study of urea cycle disordersMark L. Batshaw, Mendel Tuchman, Marshall L. Summar, Jennifer Seminara
Molecular Genetics and Metabolism. 2014-09-01 - 45 citationsClinical outcomes of neonatal onset proximal versus distal urea cycle disorders do not differ.Nicholas Ah Mew, Lauren Krivitzky, Robert McCarter, Mark L. Batshaw, Mendel Tuchman
The Journal of Pediatrics. 2013-02-01
Press Mentions
- RECORDATI RARE DISEASES: CARBAGLU® (Carglumic Acid) Tablets 200mg Receives U.S. FDA Approval for a New Indication to Treat Acute Hyperammonemia Associated with Propionic Acidemia and Methylmalonic AcidemiaJanuary 26th, 2021
- $5 Million in Federal Funding to Help Patients with Urea Cycle DisordersOctober 24th, 2019